Time to RSVP to RSV Prevention: Severe RSV Disease Burden and the Evidence Supporting RSV Vaccination and Monoclonal Antibodies

Respiratory syncytial virus (RSV) has a high burden of disease in infants as well as older adults and adults with certain risk factors. RSV can lead to severe disease, causing hospitalization and death in these populations. There have been many recent advancements in RSV disease prevention including vaccines for older adults, adults with certain risk factors, and pregnant women as well as passive immunization with monoclonal antibodies for infants and young children. Pharmacists must be aware of the full burden of disease in these patient populations and the clinical evidence supporting the use of vaccines and monoclonal antibodies to protect patients against the risk of severe RSV disease. This educational activity will use case-based examples to show the range of RSV-related diseases including the burden of hospitalization and severe cases for infants. This activity will also discuss the burden of RSV disease in adults along with risk factors for severe RSV disease including age, comorbidities, and social determinants of health. The mechanism of action, safety, efficacy, and characteristics of RSV monoclonal antibodies and vaccines will be examined, as well as methods to apply the current clinical data and real-world evidence to improve patient care and ensure patients are appropriately immunized.


Wednesday, Sept. 23
1 – 2 p.m. ET


Webinar Registration
Registration is required for this webinar.

Speakers


Monica V. Mahoney

Monica V. Mahoney, PharmD, BCPS, BCIDP, FCCP, FIDSA, FIDP, FMSHP, Activity Chair
Clinical Pharmacy Specialist – Infectious Diseases
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Monica Mahoney is a clinical pharmacy specialist in the outpatient infectious diseases and outpatient parenteral antibiotic therapy (OPAT) clinics at Beth Israel Deaconess Medical Center in Boston, Massachusetts. Dr. Mahoney received her PharmD degree from MCPHS University in Boston, Massachusetts. She completed postgraduate year 1 residency and postgraduate year 2 infectious diseases residency at Tufts Medical Center in Boston, Massachusetts. She is an active member of many pharmacy and infectious diseases professional organizations, including ASHP, the Society of Infectious Diseases Pharmacists, the Infectious Diseases Society of America, and the Society for Healthcare Epidemiology of America. She is an associate editor at Open Forum Infectious Diseases (OFID), section editor at Contagion Live, and on the editorial board for Antimicrobial Stewardship & Hospital Epidemiology (ASHE).



Sarah Parsons

Sarah Parsons, PharmD, BCPPS, FPPA
Clinical Pharmacy Specialist, Pediatric Infectious Diseases and Cystic Fibrosis
Antimicrobial Stewardship Co-Lead
The Children's Hospital of The King's Daughters
Norfolk, Virginia

Sarah Parsons is a clinical pharmacy specialist in pediatric infectious diseases and the co-lead of the antimicrobial stewardship program at the Children’s Hospital of The King’s Daughters in Norfolk, Virginia. Dr. Parsons received her Doctor of Pharmacy degree from Virginia Commonwealth University School of Pharmacy. She completed a PGY-1 residency with pediatric focus at HCA Healthcare in Richmond, Virginia. Dr. Parsons specializes in the treatment of multi-drug resistant gram negative infections, nontuberculous mycobacterium in cystic fibrosis, COVID/MIS-C, and vaccine preventable diseases in children. She is an active member of many pharmacy, pediatric, and infectious diseases professional organizations, including ASHP, the Pediatric Infectious Diseases Society, the Society of Infectious Diseases Pharmacists, the American College of Clinical Pharmacy, and is a 2025 fellow of the Pediatric Pharmacy Association.



Target Audience

This activity was planned to meet the educational needs of pharmacists who practice in hospitals, health systems, ambulatory clinics, and community settings who provide immunizations.


Learning Objectives

  • Identify patients who may be at higher risk for developing severe RSV disease.
  • Analyze the clinical evidence of RSV vaccines and monoclonal antibodies including the mechanism of action, safety, efficacy, and their different characteristics.

Agenda

  • 1 p.m. – Welcome and Introductions
    Monica Mahoney
  • 1:05 p.m. – The Burden of RSV Disease
    Monica Mahoney and Sarah Parsons
  • 1:25 p.m. – Current Clinical Evidence Supporting the Use of RSV Vaccines and Monoclonal Antibodies
    All Faculty
  • 1:50 p.m. – Faculty Discussion, Questions and Answers
    All Faculty

Accredited for CPE

ACPE #: 0204-0000-26-418-L06-P
CE Credit: 1.0 contact hour (0.1 CEU)
Activity Type: Application-based
Activity Fee: No charge

To Claim CE for the webinar, enter the CE code announced during the activity and complete the evaluation.

 


 

ACPE logo black and white The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
ASHP Advantage logo Provided by ASHP.
Supported by an independent medical educational grant from GSK.
For questions and assistance to participate, contact us.